Form 4: TransMedics Group Director David Weill Sells 2,500 Shares
SEC Form 4 Filing
Director David Weill of TransMedics Group, Inc. sold 2,500 shares of common stock at a price of $129.82 on May 10, 2024.
Summary
- On May 10, 2024, David Weill, a director of TransMedics Group, Inc., sold 2,500 shares of the company's common stock.
- The sale was executed at a price of $129.82 per share.
- Following the transaction, Weill directly owns 11,193 shares of TransMedics Group, Inc.
Sentiment
Score: 5
Explanation: This is a neutral transaction disclosure. The sale of shares by a director doesn't necessarily indicate a negative outlook, but it also doesn't provide positive sentiment.
Industry Context
This is a routine disclosure of a transaction by a company insider. It's common for directors and officers to buy and sell shares of their company's stock.
Stakeholder Impact
- The sale of shares by a director could have a minor impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 05/10/2024 | Date of stock sale transaction |
| 05/14/2024 | Date of signature on the report |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.